Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Moderate to Severe Rheumatoid Arthritis”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Post-approval studies (Phase 4)UnknownNCT05803135
What this trial is testing

Iguratimod Combined With Tofacitinib in the Treatment of Rheumatoid Arthritis

Who this might be right for
Rheumatoid Arthritis
Nanfang Hospital, Southern Medical University 138
Not applicableStudy completedNCT04497597
What this trial is testing

Oral Upadacitinib Tablets to Assess Treatment Patterns, Achievement of Treatment Targets and Maintenance of Response in Adult Participants With Moderate to Severe Rheumatoid Arthritis

Who this might be right for
Rheumatoid Arthritis (RA)
AbbVie 1,532
Testing effectiveness (Phase 2)Study completedNCT02983227
What this trial is testing

Evaluate the Long-Term Safety and Efficacy of GDC-0853 in Participants With Moderate to Severe Rheumatoid Arthritis Enrolled in Study GA29350

Who this might be right for
Rheumatoid Arthritis
Genentech, Inc. 496
Testing effectiveness (Phase 2)Study completedNCT02287922
What this trial is testing

A Phase IIb Study for ALX-0061 Monotherapy in Subjects With Rheumatoid Arthritis

Who this might be right for
Rheumatoid Arthritis
Ablynx, a Sanofi company 251
Not applicableStudy completedNCT01362062
What this trial is testing

Study to Evaluate the Safety, Tolerability and Efficacy of Tocilizumab in Participants With Rheumatoid Arthritis (RA) Who Have an Inadequate Response to Non-Biologic Disease Modifying Anti-rheumatic Drugs (DMARDs) and/or Anti-tumor Necrosis Factor (Anti-TNF) Therapy

Who this might be right for
Rheumatoid Arthritis
Hoffmann-La Roche 110
Testing effectiveness (Phase 2)Study completedNCT00887341
What this trial is testing

A Study Comparing Infusion Rates of Tocilizumab in Patients With Moderate to Severe Rheumatoid Arthritis

Who this might be right for
Rheumatoid Arthritis
Hoffmann-La Roche 76
Large-scale testing (Phase 3)Study completedNCT02293902
What this trial is testing

A Study Assessing the Efficacy and Safety of Sarilumab Added to MTX in Japanese Patients With Moderately to Severely Active Rheumatoid Arthritis (SARIL-RA-KAKEHASI)

Who this might be right for
Rheumatoid Arthritis
Sanofi 243
Post-approval studies (Phase 4)Looking for participantsNCT07554820
What this trial is testing

Major Adverse Cardiovascular Events (MACE) in Rheumatoid Arthritis Patient With Moderate to Severe Disease Activity Treated With Tofacitinib and Statins vs TNF Inhibitors: TOFSTAT CLINICAL TRIAL

Who this might be right for
Rheumatoid ArthritisMajor Adverse Cardiac Events
Shaikh Zayed Hospital, Lahore 120
Large-scale testing (Phase 3)Study completedNCT02706951
What this trial is testing

A Study Comparing Upadacitinib (ABT-494) Monotherapy to Methotrexate (MTX) Monotherapy in Adults With Rheumatoid Arthritis (RA) Who Have an Inadequate Response to MTX (SELECT-MONOTHERAPY)

Who this might be right for
Rheumatoid Arthritis
AbbVie 648
Large-scale testing (Phase 3)Study completedNCT01655381
What this trial is testing

A Long-Term Extension Study of WA19926 on the Safety of Tocilizumab (RoActemra/Actemra) in Participants With Early Moderate to Severe Rheumatoid Arthritis

Who this might be right for
Rheumatoid Arthritis
Hoffmann-La Roche 15
Testing effectiveness (Phase 2)Study completedNCT04204603
What this trial is testing

A Study Evaluating the Efficacy and Safety of CKD-506 in Adult Subjects With Moderate-to-Severe Rheumatoid Arthritis and Inadequate Response to Methotrexate

Who this might be right for
Rheumatoid Arthritis
Chong Kun Dang Pharmaceutical 122
Post-approval studies (Phase 4)Study completedNCT03608761
What this trial is testing

Comparison Between Rebamipide 2% Versus Autologous Serum

Who this might be right for
Dry Eye SyndromesSjögren Syndrome
Hospital Nacional Profesor Alejandro Posadas 21
Early research (Phase 1)Study completedNCT02717988
What this trial is testing

Safety, Tolerability, and Pharmacokinetics of a Single Oral Dose of SKI-O-703 in Healthy Volunteers

Who this might be right for
Rheumatoid Arthritis
Oscotec Inc. 48
Testing effectiveness (Phase 2)Study completedNCT00205478
What this trial is testing

Phase 2 Clinical Study in Rheumatoid Arthritis With an Investigational Oral p38 MAP Kinase Inhibitor VX-702

Who this might be right for
Rheumatoid Arthritis
Vertex Pharmaceuticals Incorporated 300
Large-scale testing (Phase 3)Study completedNCT01885078
What this trial is testing

An Extension Study in Participants With Moderate to Severe Rheumatoid Arthritis

Who this might be right for
Rheumatoid Arthritis
Eli Lilly and Company 2,877
Testing effectiveness (Phase 2)Study completedNCT01373151
What this trial is testing

Phase IIB Rheumatoid Arthritis Dose Ranging Study for BMS-945429 in Subjects Who Are Not Responding to Methotrexate

Who this might be right for
Rheumatoid Arthritis
CSL Behring 418
Large-scale testing (Phase 3)Study completedNCT02638259
What this trial is testing

Comparative Efficacy and Safety Study of GP2015 and Enbrel® in Patients With Rheumatoid Arthritis

Who this might be right for
Rheumatoid Arthritis
Sandoz 376
Testing effectiveness (Phase 2)Active Not RecruitingNCT06041269
What this trial is testing

Efficacy and Safety of Rosnilimab in Subjects with Moderate to Severe Rheumatoid Arthritis (RENOIR)

Who this might be right for
Rheumatoid Arthritis
AnaptysBio, Inc. 420
Testing effectiveness (Phase 2)Ended earlyNCT01390545
What this trial is testing

VELVET, a Dose Range Finding Trial of Veltuzumab in Subjects With Moderate to Severe Rheumatoid Arthritis

Who this might be right for
Rheumatoid Arthritis
Takeda 300
Not applicableStudy completedNCT01741688
What this trial is testing

An Observational Study of Tocilizumab (Actemra) in Participants With Moderate to Severe Rheumatoid Arthritis

Who this might be right for
Rheumatoid Arthritis
Hoffmann-La Roche 16
Next Page